Support our Foundation of Myology project
1655 news items
Pregnancy in a woman with myasthenia gravis, a risky situation
On 05/10/2022
The Healthcare cost and utilization project, nationwide inpatient sample (HCUP-NIS) database includes information on more than 7 million hospital stays in the United States each…
Inhibiting the proteasome to treat OPMD
On 04/10/2022
Researchers from the University of Montpellier, supported by the AFM-Telethon, have shown that muscle cell damage in oculopharyngeal muscular dystrophy (OPMD) is mediated by overactivation…
A non-Kennedy SBMA linked to the UBA1 gene
On 04/10/2022
A new form of bulbospinal muscular atrophy has just been described by Iranian clinicians in 4 patients: it is an SBMA linked to the UBA1…
Early-onset SMA: a German real-life study of children treated with nusinersen
On 03/10/2022
Analysis of data collected by the German-speaking SMArtCARE observatory of 143 patients under 18 years of age with early-onset SMA who had not acquired sitting…
30 September: International Muscular Dystrophy Awareness Day
On 29/09/2022
The 8th International Limb Girdle Muscular Dystrophy Awareness Day will take place on 30 September. Organised by the LGMD Awareness Foundation, the aim of this…
FKRP Limb-girdle muscular dystrophy : 1st patient treated in the European gene therapy clinical trial
On 29/09/2022
The AFM-Telethon and its laboratory Genethon are delighted with the treatment of the first patient included in the European gene therapy trial for limb-girdle muscular…
Moxifloxacin, an antibiotic of interest in SMA
On 29/09/2022
An I-STEM team identified moxifloxacin for its ability to increase SMN protein production in a cell-based model screen of already marketed molecules. Administered daily subcutaneously…
10th edition of the “1000 researchers in schools” campaign – 7 Nov-3 Dec
On 28/09/2022
The scientific campaign operation for secondary school students “1000 researchers in schools in France and abroad” is celebrating its 10th anniversary! It will take place…
A review of the literature compares prednisone and deflazacort in DMD and favours the latter in the short term, while in the long term their effects are similar
On 22/09/2022
Corticosteroids prescribed from the age of 4 to 5 years in Duchenne muscular dystrophy enable the loss of walking to be delayed by at least…
ERN EURO-NMD webinar, Sept. 22nd : Prof. Costanza Lamperti (Italy)
On 22/09/2022
Mitochondrial Genetics Thursday September 22nd, 2022 – 16:00-17:00 (Paris time) Prof. Costanza Lamperti (lstituto Neurologico C.Besta, Milan, Italy) Please register here to attend the webinar Webinar…
What alternative to face-to-face rehabilitation in DMD?
On 19/09/2022
In a study published in May 2022, a Turkish team carried out a measurement of muscle strength and a functional evaluation of motor performance in…
Myology 2022: opening session
On 16/09/2022
On Monday, September 12, took place the opening session of the 7th edition of the international congress Myology 2022 was held with Laurence Tiennot-Herment, president…
McArdle: clinical trial proves benefits of exercise
On 14/09/2022
A clinical trial of 17 people with McArdle’s disease demonstrated the potential benefits of a 2-year training program targeting endurance and strength. Six of the…
Myology 2022: Institute of Myology experts will highlight their last scientific results
On 09/09/2022
During four days, from 12 to 15th of September, researchers and clinicians of the Institute of Myology will attend the seventh International Congress of Myology,…
REDs lab offers a post-doctoral position
On 06/09/2022
RNA metabolism and astrocyte dysfunction in myotonic dystrophy A two-year postdoctoral position is available from early 2023, in the laboratory Repeat Expansions and Myotonic Dystrophy,…
Diaphragm involvement in Pompe disease more clearly visualized on imaging
On 02/09/2022
The diaphragmatic muscle is a key muscle in Pompe disease, which causes its dysfunction due to a toxic accumulation of glycogen. Dutch researchers studied this…
Rituximab is proving to be an effective background treatment for MG, including in children
On 02/09/2022
Rituximab is an injectable monoclonal antibody that depletes B lymphocytes (CD20+); it is increasingly used in autoimmune diseases, including myasthenia. A Spanish study confirmed its…
MCR Seminar – 2 September – Ana Ferreiro
On 01/09/2022
Ana Ferreiro – Translational research in core myopathies : ‘from bedside to bench and back’ The Myology Center for Research (UMR974) is pleased to invite…
A novel method to treat recurrent pneumothorax in Ullrich myopathy
On 01/09/2022
American authors report the case of a 19-year-old patient suffering from Ullrich myopathy (collagen VI deficiency) since childhood and who presented a recurrent pneumothorax in…
ACTA1 gene-related nemaline myopathies: an international study to clarify phenotypes
On 31/08/2022
Pathological variants of the ACTA1 gene are responsible for half of the cases of nemaline myopathy (also known as rod myopathy). An international collaboration coordinated…